- Home
- ATYR vs TBRG Comparison
ATYR vs TBRG Comparison
Compare ATYR & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- TBRG
- Stock Information
- Founded
- ATYR 2005
- TBRG 1979
- Country
- ATYR United States
- TBRG United States
- Employees
- ATYR N/A
- TBRG N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- TBRG
- Sector
- ATYR Health Care
- TBRG
- Exchange
- ATYR Nasdaq
- TBRG NYSE
- Market Cap
- ATYR 228.1M
- TBRG 186.6M
- IPO Year
- ATYR 2015
- TBRG N/A
- Fundamental
- Price
- ATYR $2.98
- TBRG $16.01
- Analyst Decision
- ATYR Strong Buy
- TBRG Buy
- Analyst Count
- ATYR 4
- TBRG 3
- Target Price
- ATYR $19.25
- TBRG $14.67
- AVG Volume (30 Days)
- ATYR 877.6K
- TBRG 56.8K
- Earning Date
- ATYR 11-07-2024
- TBRG 11-07-2024
- Dividend Yield
- ATYR N/A
- TBRG N/A
- EPS Growth
- ATYR N/A
- TBRG N/A
- EPS
- ATYR N/A
- TBRG N/A
- Revenue
- ATYR $235,000.00
- TBRG $337,674,000.00
- Revenue This Year
- ATYR N/A
- TBRG $0.94
- Revenue Next Year
- ATYR $2,057.69
- TBRG $4.58
- P/E Ratio
- ATYR N/A
- TBRG N/A
- Revenue Growth
- ATYR N/A
- TBRG 0.26
- 52 Week Low
- ATYR $1.14
- TBRG $7.55
- 52 Week High
- ATYR $3.80
- TBRG $16.73
- Technical
- Relative Strength Index (RSI)
- ATYR 49.97
- TBRG 72.45
- Support Level
- ATYR $2.81
- TBRG $15.40
- Resistance Level
- ATYR $3.80
- TBRG $16.62
- Average True Range (ATR)
- ATYR 0.25
- TBRG 0.71
- MACD
- ATYR -0.08
- TBRG 0.21
- Stochastic Oscillator
- ATYR 17.17
- TBRG 82.29
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.